Skip to content

Author

Jinfeng Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Genome-wide CRISPR screen identifies ATAD3A promotes acetaminophen-induced liver injury by driving ferroptosis

Acetaminophen (APAP) overdose is a major cause of acute liver injury, yet effective therapeutic targets remain scarce. This study investigated the genes regulating hepatocyte vulnerability to APAP toxicity and the underlying mechanisms. Genome-wide CRISPR loss-of-function screening was performed in hepatocytes expose...

Jin-Feng Liu, Zi-Han Gao, Shuai Ding et al. · 0 citations
Review Jul 2026

Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies

Biological and translational evidence is synthesized to examine factors that may constrain the clinical efficacy of GPC3-targeted therapies, including antigen-related features, tumor microenvironment–associated barriers, and platform-specific challenges.

Na Li, Shu-Rong Li, P. Cao et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.